Paradigm Biopharmaceuticals Limited [ASX:PAR] share price and news 2022

Company Description

Paradigm Biopharmaceuticals Limited (PAR) is involved in researching and developing therapeutic products for human use. It is a drug repurposing company which seeks to find new uses for old drugs, thereby reducing the cost and time to bring therapeutics to market.

Paradigm Biopharmaceuticals Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website:

This a small cap company with market cap of 555 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 5.11 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how par dividend grows in the recent years.

No data